4//SEC Filing
Rangwala Reshma 4
Accession 0001209191-22-026425
CIK 0001503802other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:01 PM ET
Size
7.5 KB
Accession
0001209191-22-026425
Insider Transaction Report
Form 4
Rangwala Reshma
EVP & Chief Medical Officer
Transactions
- Award
Common Stock
2022-04-29+65,000→ 65,000 total - Award
Stock Option (right to buy)
2022-04-29+100,000→ 100,000 totalExercise: $6.10Exp: 2032-04-28→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Inducement Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning April 29, 2023.
- [F2]This option was granted on April 29, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on April 29, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001825322
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:01 PM ET
- Size
- 7.5 KB